Makers Laboratories Ltd (506919)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Makers Laboratories' revenue was ₹42.8 Cr (+22.2% year on year, +19.6% on the previous quarter), and net profit ₹4.6 Cr (+256.3% year on year); the operating margin was 16.3%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹42.8 | +22.2% | +19.6% |
| Operating profit | ₹7.0 | +131.3% | +31.9% |
| Net profit | ₹4.6 | +256.3% | +29.1% |
| EPS (₹) | 2.55 | +240.0% | +37.8% |
| Operating margin | 16.3% | — | — |
📢 Recent Corporate Announcements
Makers Laboratories has announced that Mr. Saahil Parikh will step down as Whole-time Director and CEO effective August 10, 2026, transitioning to a Non-Executive, Non-Independent Director role. For the quarter ended June 30, 2026, the company reported consolidated revenue of Rs 42.77 Cr, a 22.2% increase from Rs 35.00 Cr in the previous year's corresponding quarter. Consolidated net profit rose to Rs 1.09 Cr from Rs 0.44 Cr YoY. However, the standalone business remains under pressure, reporting a net loss of Rs 0.27 Cr for the quarter.
- Mr. Saahil Parikh transitions from CEO/Whole-time Director to Non-Executive Director effective August 11, 2026
- Consolidated Revenue for Q1 FY27 increased to Rs 42.77 Cr from Rs 35.00 Cr YoY
- Consolidated Net Profit for the quarter improved to Rs 1.09 Cr compared to Rs 0.44 Cr in Q1 FY26
- Standalone operations reported a net loss of Rs 0.27 Cr on revenue of Rs 13.73 Cr
- Mr. Nilesh Jain remains as the sole Executive Whole-time Director following the board reconstitution
Makers Laboratories reported a strong consolidated performance for Q1 FY27, with revenue growing 22.2% YoY to ₹42.77 Cr. Consolidated Net Profit attributable to owners surged 150% to ₹1.09 Cr, up from ₹0.44 Cr in the previous year's quarter. However, standalone operations remain a concern, posting a net loss of ₹1.08 Cr. The company also announced that CEO Saahil Parikh will transition to a Non-Executive Director role effective August 11, 2026, following the end of his current term.
- Consolidated Revenue from Operations increased 22.2% YoY to ₹42.77 Cr from ₹35.00 Cr.
- Consolidated Net Profit (attributable to owners) rose 150% to ₹1.09 Cr compared to ₹0.44 Cr in Q1 FY26.
- Standalone operations reported a net loss of ₹1.08 Cr, slightly higher than the ₹0.96 Cr loss in the year-ago period.
- CEO Saahil Parikh to step down from executive duties on August 10, 2026, remaining as a Non-Executive Director.
- Consolidated EPS improved to ₹1.85 from ₹0.74 YoY.
Makers Laboratories reported a consolidated revenue of Rs 42.77 Cr for Q1 FY27, representing a 22.2% increase compared to Rs 35.00 Cr in the same quarter last year. Net profit attributable to owners rose to Rs 1.09 Cr from Rs 0.44 Cr YoY, though it declined sequentially from Rs 1.50 Cr in March 2026. A significant divergence persists between consolidated and standalone performance, with the standalone entity reporting a net loss of Rs 1.72 Cr. Additionally, CEO Saahil Parikh will transition to a Non-Executive Director role effective August 11, 2026, upon the completion of his current term.
- Consolidated Revenue from Operations grew 22.2% YoY to Rs 42.77 Cr.
- Net Profit attributable to owners increased to Rs 1.09 Cr from Rs 0.44 Cr in the year-ago period.
- Standalone operations reported a net loss of Rs 1.72 Cr for the quarter ended June 30, 2026.
- CEO Saahil Parikh transitions to a Non-Executive, Non-Independent Director role effective August 11, 2026.
- Consolidated Total Income for the quarter stood at Rs 43.38 Cr compared to Rs 35.27 Cr YoY.
Makers Laboratories Ltd has scheduled a board meeting on August 7, 2026, to approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. This follows a strong March 2026 quarter where the company reported a net profit of ₹3.56 cr on revenue of ₹35.75 cr. The trading window for insiders has been closed since July 1, 2026, and will remain so until August 9, 2026. This is a routine regulatory notification as per SEBI Listing Obligations.
- Board meeting scheduled for August 7, 2026, to review Q1 FY27 performance
- Trading window for insiders closed for 40 days from July 1 to August 9, 2026
- Company reported a TTM revenue of ₹141 cr and TTM PAT of ₹8 cr
- Previous quarter (Mar 2026) showed an operating profit margin of approximately 14.7%
- Promoter holding remains stable at 61.28% as of June 2026
Makers Laboratories has scheduled its 41st Annual General Meeting (AGM) for August 7, 2026, to be conducted via video conferencing. The company has released the web-link for its FY 2025-26 Annual Report and sent physical intimations to shareholders whose email addresses are not registered. The filing also serves as a reminder for mandatory KYC updates for physical shareholdings as per SEBI mandates. Shareholders are encouraged to review the report for detailed financial performance of the previous fiscal year.
- 41st Annual General Meeting scheduled for August 7, 2026, at 12:30 PM IST
- Cut-off date for identifying shareholders without registered emails was July 3, 2026
- Annual Report for Financial Year 2025-26 made available via a dedicated web-link
- Mandatory electronic payment of dividends effective from April 1, 2024, for KYC-compliant folios
- KYC updates required for physical holders include PAN, mobile number, and bank account details
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
